Marinol and Lenvima drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Marinol (dronabinol) and Lenvima (lenvatinib mesylate). Common drug interactions include dehydration among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Marinol and Lenvima. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Marinol?

Marinol has active ingredients of dronabinol. It is often used in pain. eHealthMe is studying from 4,963 Marinol users. Check the latest studies of Marinol.

What is Lenvima?

Lenvima has active ingredients of lenvatinib mesylate. eHealthMe is studying from 21,113 Lenvima users. Check the latest studies of Lenvima.

On Jul, 07, 2026

17 people who take Marinol and Lenvima together, and have interactions are studied.

What are the common drug interactions of Marinol and Lenvima, by gender? *:

female:

Dehydration (dryness resulting from the removal of water)
Decreased appetite
Fatigue (feeling of tiredness)
Diarrhoea
Vomiting
Constipation
Blood pressure increased
Dizziness
Weight decreased
Malignant neoplasm progression (cancer tumour came back)

male:

Diarrhoea
Decreased appetite
Myalgia (muscle pain)
Neuropathy peripheral (surface nerve damage)
Oral candidiasis (fungal infection of mouth)
Oral mucosal blistering (mouth ulcer)
Overdose
Peripheral swelling
Portal vein occlusion (venous thrombosis affecting the hepatic portal vein)
Skin wrinkling (wrinkle on skin)

What are the common drug interactions of Marinol and Lenvima, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Constipation
Dizziness
Malignant neoplasm progression (cancer tumour came back)
Pleural effusion (water on the lungs)
Abdominal pain upper
Blood pressure increased
Chest pain
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dyspnoea (difficult or laboured respiration)

60+:

Diarrhoea
Decreased appetite
Arthralgia (joint pain)
Blood potassium decreased
Blood pressure increased
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Heart rate increased
Hypertension (high blood pressure)
Intestinal perforation (complete penetration of the wall of the intestine)
Myalgia (muscle pain)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 5 people, 29.41%
Endometrial Cancer: 5 people, 29.41%
Hepatocellular Carcinoma (liver cancer): 3 people, 17.65%
Thyroid Cancer: 2 people, 11.76%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 11.76%
Urinary Tract Infection: 1 person, 5.88%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 5.88%
Metastases To Ovary (cancer spreads to ovary): 1 person, 5.88%
Appetite Disorder (abnormal eating habits): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Marinol and Lenvima?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously